UNICON PHARMA H-1B Visa Sponsorship & Salary Data

The median H-1B salary at UNICON PHARMA is $83,200, based on 115 certified filings from FY 2020 to FY 2023. This is 31% lower than the national H-1B median salary of $120,000. Compensation at UNICON PHARMA reflects their market positioning, with entry-level roles starting around $77,106 and senior positions reaching $104,395 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at UNICON PHARMA range from $67,538 at the 10th percentile to $104,395 at the 90th percentile, showing a $36,857 spread across experience levels and roles. The 25th percentile is $77,106 and the 75th percentile is $89,877.

Yes, UNICON PHARMA actively sponsors H-1B visas and has been a consistent participant in the H-1B program. They have filed 150 H-1B labor condition applications from FY 2020 to FY 2023, demonstrating ongoing commitment to hiring international talent. With 115 certified applications and a 0.7% denial rate, UNICON PHARMA maintains a strong track record for H-1B sponsorship. The company sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2023), UNICON PHARMA filed 1 H-1B applications, with 1 certified and 0 denied. Over 3 years of data, UNICON PHARMA has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

UNICON PHARMA's LCA (Labor Condition Application) denial rate is 0.7%, with 1 out of 150 applications denied across all years. This translates to a 99.3% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating UNICON PHARMA as a potential H-1B sponsor.

This is a good approval rate, comparable to industry averages. UNICON PHARMA demonstrates reliable H-1B sponsorship practices.

UNICON PHARMA sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 115 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles UNICON PHARMA most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at UNICON PHARMA:

The most frequently sponsored role is Validation Engineer with 35 filings at a median salary of $80,725. This is followed by Validation Analyst (23 filings) and Pv Operations Associate.

UNICON PHARMA's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where UNICON PHARMA sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top UNICON PHARMA H-1B locations:

The largest H-1B hub for UNICON PHARMA is Rahway, NJ with 9 filings at a median salary of $83,200. The highest-paying location is Foster City, CA at $90,147 median. Salaries range from $67,538 to $90,147 across office locations.

UNICON PHARMA's median H-1B salary has increased by +5% from FY 2020 ($83,200) to FY 2023 ($87,422). Tracking salary trends over time reveals how UNICON PHARMA adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at UNICON PHARMA.

Year-by-year breakdown:

• FY 2020: $83,200 (82 certified)
• FY 2021: $81,682 (32 certified)
• FY 2023: $87,422 (1 certified)

UNICON PHARMA has maintained steady salary growth for H-1B positions over this period.

UNICON PHARMA primarily files H-1B applications at Wage Level II, accounting for 71% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making UNICON PHARMA's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 100% of positions at Level II or higher, UNICON PHARMA typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

UNICON PHARMA's median H-1B salary of $83,200 is 31% lower than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating UNICON PHARMA's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare UNICON PHARMA's offerings with similar companies in your field for a more accurate assessment.

UNICON PHARMA's H-1B salaries are below the national median, though this may vary significantly by role, experience level, and location. Consider researching specific positions for more accurate compensation expectations.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. UNICON PHARMA files 0% of positions at Level I, which may face more lottery competition under wage-level prioritization rules.

With 115 certified filings, UNICON PHARMA invests significantly in H-1B sponsorship. The company's 0.7% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.